TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF
Ngày 16/10/2020 11:49 | Lượt xem: 92

An interim analysis of the Restore EF Study, presented at TCT Connect 2020 (14–18 October, virtual), demonstrates the use of contemporary best practices, including attempting a more complete revascularisation with Impella-supported high-risk percutaneous coronary intervention (PCI), is associated with significant improvement of left ventricular ejection fraction (LVEF), heart failure symptoms, and anginal symptoms at follow-up. The analysis was presented by Mitul Patel, MD, an interventional cardiologist at UC San Diego Health, San Diego, USA.

The ongoing, multicentre, prospective, single-arm study enrolled 193 consecutive qualified patients who underwent a Protected PCI procedure with Impella between September 2019 and September 2020 at 19 hospitals in the USA, representing a variety of hospital settings including rural, urban, community and academic centres. The interim analysis showed:

  • Significant median LVEF improvement from baseline to 90-day follow up (31% to 45% p<0.0001). LVEF improvement at 90 days is the study’s primary endpoint.
  • Significant reduction of heart failure symptoms with 80% reduction in New York Heart Association (NYHA) classification III/IV at follow up (54% to 11% p<0.001).
  • Significant reduction of anginal symptoms with 99% reduction in Canadian Cardiovascular Society (CCS) classification III/IV at follow up (70% to 1% p<0.0001).

“Restore EF demonstrates Impella-supported PCI patients have shown a significant LVEF improvement at 90 days. The study also found a significant improvement in heart failure and anginal symptoms assessed with NYHA and CCS functional classifications,” said Patel. “Taken together, this data validates best practices for treating high-risk PCI patients, including the use of Impella to achieve a complete revascularisation in a single setting.”

“High-risk PCI patients often pose a revascularisation challenge due to patient comorbidities, poor LV function, and adverse haemodynamics, which drive worse outcomes. This research demonstrates the rationale for using Impella support during high-risk PCI to maintain coronary perfusion and support haemodynamics during periods of myocardial ischaemia during long or repeated balloon inflations or atherectomy runs. This allows providers to achieve complete functional revascularisation and the best possible outcomes for our patients,” said Jason Wollmuth, an interventional cardiologist at Providence Health and Vascular Institute, Providence, USA and a co-principal investigator of the Restore EF Study.

Findings from Restore EF will be used to inform the study protocol for the upcoming PROTECT IV Randomised Controlled Trial. PROTECT IV will be a prospective, two-arm trial that will compare complete revascularisation PCI with Impella to complete revascularisation PCI without any planned haemodynamic support. PROTECT IV is part of the Impella clinical evidence pathway to a Class I clinical guideline recommendation for high-risk PCI. The Restore EF study is sponsored by Abiomed.

Source CardiovascularNews

Duc Tin Clinic

Print Chia sẽ qua facebook bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua google bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua twitter bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua MySpace bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua LinkedIn bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua stumbleupon bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua icio bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua digg bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua yahoo bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua yahoo bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua yahoo bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF Chia sẽ qua yahoo bài: TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF

Tin tức liên quan

CUSTOMER REVIEWS

  • I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

    I sincerely thank you !. Tel: 0938303275

  • Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

    Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

  • As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

  • The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

  • I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search
Customer support

    Phone: (028) 3981 2678
    Mobile: 0903 839 878 - 0909 384 389

TOP